Issue 93, 2021

A visible light-controllable Rho kinase inhibitor based on a photochromic phenylazothiazole

Abstract

Rho-associated coiled-coil-containing protein kinase (ROCK) is a serine–threonine kinase whose inhibitors are useful for the regulation of the actomyosin system. Here, we developed a photoswitchable ROCK inhibitor based on a phenylazothiazole scaffold. The reversible transcis isomerization by visible light stimuli enabled us to manipulate ROCK activities in vitro and in cells.

Graphical abstract: A visible light-controllable Rho kinase inhibitor based on a photochromic phenylazothiazole

Supplementary files

Article information

Article type
Communication
Submitted
01 Sep 2021
Accepted
29 Oct 2021
First published
29 Oct 2021

Chem. Commun., 2021,57, 12500-12503

Author version available

A visible light-controllable Rho kinase inhibitor based on a photochromic phenylazothiazole

K. Matsuo, S. Thayyil, M. Kawaguchi, H. Nakagawa and N. Tamaoki, Chem. Commun., 2021, 57, 12500 DOI: 10.1039/D1CC04905D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements